Synthetic Lignin-Derived Therapeutic Nano Reagent as Intestinal pH-Sensitive Drug Carriers Capable of Bypassing the Gastric Acid Environment for Colitis Treatment

Abstract

Oral drug delivery is a common route for management of inflammatory bowel disease (IBD) but suffers from low bioavailability and systemic side effects during passage through the alimentary canal. Here, we present a therapeutic nano reagent of a ferulic acid-derived lignin nanoparticle (FALNP). We showed that FALNP with favorable antioxidant activity can regulate IBD. More importantly, the intestinal pHresponsive degradability of FALNP allows it to withstand the harsh gastric acid environment, bypass physiological barriers, and target the intestine for gastrointestinal delivery. In vivo experiments showed that oral administration of FALNP markedly relieved pathological symptoms in a mouse model of acute colitis by reducing oxidative stress and regulating the gut microbiome. By integrating anti-inflammatory medicine, FALNP also can be used as a bioactive carrier to exert a potent synergistic therapeutic effect. In addition to colitis, FALNP can be readily adaptable for use as a carrier platform for therapy of many other intestinal diseases.

Strategic Assessment of Boron-Enriched Carbon Dots/Naproxen: Diagnostic, Toxicity, and In Vivo Therapeutic Evaluation

“…The pH range selected for this test ranges from 1 to 12, representing the pH levels of the numerous organs that the drug will encounter during its path through the body. The stomach, for example, maintains an exceedingly acidic environment, with a pH range of 1 to 3, whereas the intestines tend toward neutral to alkaline conditions . According to the graph, no sediments or aggregates were formed during the observations with pH, NaCl concentration, and temperature range under human condition.…”

Orally-administered nanomedicine systems targeting colon inflammation for the treatment of inflammatory bowel disease: latest advances

“…5D). 106 While targeting the intestinal pH environment through orally administered nanocarrier systems holds great promise as an efficient strategy for IBD treatment, research suggests that Fig. 5 pH responsive NPs drug delivery systems.…”

Calcium Tungstate Microgel Enhances the Delivery and Colonization of Probiotics during Colitis via Intestinal Ecological Niche Occupancy

“…Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, is a chronic inflammatory disease of the gastrointestinal (GI) tract. , Due to its uncertain multifactorial etiology, the rising incidence of colitis represents a major health burden worldwide . Immunosuppressive agents, which suppress the immune response and can cause severe side effects due to their nonspecific immunomodulatory effects, are typically the first-line treatment for colitis. − As an improvement, the most recent therapies, such as infliximab and adalimumab, have shown high colitis control rates.…”